Avantor

US · AVTR #1438 by market cap Listed 2019

15.35 -0.08 -0.52%

Live - 5344 symbols - heartbeat 190s ago · 2026-10-07 19:54

After-hours 15.35 0.00%

Market cap: 10.38B
P/E (TTM): -18.06
P/B: 1.84
EPS: -0.78
Div yield: 0.00%
52W pos: 89%

Reader sentiment Are you bullish or bearish on AVTR?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Financial Health how this is computed

Fair

Altman Z-Score is 2.02, in the 1.8-3.0 "grey zone".
Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.

Revenue annual, last 8 years

Latest year -3.41% YoY

Margins

Gross margin: 32.65%
Operating margin: 8.30%
Net margin: -8.09%

Key ratios & quality

Enterprise value: 13.96B
Altman Z-Score: 2.02

Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.

Income statement

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	5.86B	6.04B	6.39B	7.39B	7.51B	6.97B	6.78B	6.55B
Gross profit	1.82B	1.92B	2.08B	2.50B	2.60B	2.36B	2.28B	2.14B
Selling & admin expenses	1.41B	1.37B	1.37B	1.53B	1.47B	1.51B	1.64B	1.60B
Research & development	--	--	--	--	--	--	--	--
Operating profit	413.50M	551.80M	706.80M	972.20M	1.13B	857.20M	638.20M	543.90M
Pretax profit	-113.80M	40.60M	62.30M	753.00M	851.10M	410.50M	853.90M	-441.30M
Tax	-26.90M	2.80M	-54.30M	180.40M	164.60M	89.40M	142.40M	88.90M
Net profit	-86.90M	37.80M	116.60M	572.60M	686.50M	321.10M	711.50M	-530.20M
Basic EPS	-1	-1	0	1	1	0	1	-1
Diluted EPS	-0.72	-0.84	0.09	0.85	1.01	0.47	1.04	-0.78

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
Revenue	1.58B	1.68B	1.62B	1.66B	1.58B	1.69B
Gross profit	534.90M	554.10M	526.50M	523.90M	500.70M	537.00M
Selling & admin expenses	387.50M	425.30M	390.30M	392.40M	401.20M	415.20M
Research & development	--	--	--	--	--	--
Operating profit	147.40M	128.80M	136.20M	131.50M	99.50M	121.80M
Pretax profit	85.70M	81.70M	-689.50M	80.80M	55.50M	81.20M
Tax	21.20M	17.00M	22.30M	28.40M	12.20M	43.10M
Net profit	64.50M	64.70M	-711.80M	52.40M	43.30M	38.10M
Basic EPS	0	0	-1	0	0	0
Diluted EPS	0.09	0.09	-1.04	0.08	0.06	0.06

Balance sheet

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Total current assets	1.90B	2.02B	2.23B	2.48B	2.66B	2.38B	2.15B	2.45B
Cash & ST investments	184.70M	186.70M	286.60M	301.70M	372.90M	262.90M	261.90M	365.40M
Inventory	671.10M	711.20M	739.60M	872.00M	913.50M	828.10M	731.50M	818.20M
Total assets	9.91B	9.77B	9.91B	13.90B	13.46B	12.97B	12.11B	11.79B
Total current liabilities	1.10B	1.07B	1.24B	1.45B	1.66B	1.48B	2.01B	1.38B
Short-term debt	142.40M	93.50M	26.40M	45.20M	364.20M	259.90M	821.10M	30.80M
Long-term debt	6.78B	5.02B	4.87B	6.98B	5.92B	5.28B	3.23B	3.92B
Total liabilities	12,963,300,000.00	7,311,100,000.00	7,232,200,000.00	9,700,200,000.00	8,608,900,000.00	7,720,100,000.00	6,157,800,000.00	6,229,700,000.00
Total equity	-3.05B	2.46B	2.67B	4.20B	4.86B	5.25B	5.96B	5.57B
Retained earnings	-238.40M	-203.70M	-88.70M	483.90M	1.17B	1.49B	2.20B	1.67B

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
Total current assets	2.28B	2.51B	2.26B	2.45B	2.40B	2.46B
Cash & ST investments	315.70M	449.40M	251.90M	365.40M	279.30M	306.80M
Inventory	750.10M	779.80M	795.50M	818.20M	810.30M	828.70M
Total assets	12.33B	12.78B	11.68B	11.79B	11.66B	11.60B
Total current liabilities	2.03B	2.58B	1.52B	1.38B	1.37B	1.38B
Short-term debt	827.50M	1.25B	219.80M	30.80M	37.00M	37.00M
Long-term debt	3.28B	2.99B	3.64B	3.92B	3.78B	3.66B
Total liabilities	6,228,200,000.00	6,491,000,000.00	6,105,700,000.00	6,229,700,000.00	6,074,300,000.00	5,965,700,000.00
Total equity	6.10B	6.29B	5.57B	5.57B	5.59B	5.63B
Retained earnings	2.27B	2.33B	1.62B	1.67B	1.72B	1.75B

Cash flow

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Operating cash flow	200.50M	354.00M	929.80M	953.60M	843.60M	870.00M	840.80M	623.80M
Depreciation & amortization	404.60M	398.90M	395.40M	379.20M	405.50M	402.30M	405.50M	410.20M
Free cash flow	162.80M	302.40M	868.20M	842.50M	710.20M	723.60M	692.00M	495.00M
Dividends paid	0	-31.30M	-64.60M	-64.60M	-32.40M	--	--	--
Stock buybacks / issuance	0	4.24B	0	941.20M	-13.20M	-13.70M	-8.60M	-80.70M
Ending cash balance	187.70M	189.30M	289.20M	327.10M	396.90M	287.70M	264.70M	368.30M

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
Operating cash flow	109.30M	154.40M	207.40M	152.70M	58.70M	178.20M
Depreciation & amortization	99.70M	102.70M	104.50M	103.30M	105.00M	105.60M
Free cash flow	81.30M	124.80M	171.70M	117.20M	25.20M	140.60M
Dividends paid	--	--	--	--	--	--
Stock buybacks / issuance	-4.90M	-100.00K	-400.00K	-75.30M	-3.60M	-300.00K
Ending cash balance	318.50M	452.20M	254.70M	368.30M	282.20M	309.70M

Returns & efficiency

Line item	2018	2019	2020	2021	2022	2023	2024	2025
ROE %	--	--	3.32	20.89	16.46	6.35	12.69	-9.20
ROA %	-0.85	-3.40	0.53	4.27	4.84	2.43	5.67	-4.44
ROIC %	--	--	4.21	8.02	8.21	4.96	8.59	-4.06
5-year avg ROE %	--	--	--	--	--	--	11.94	9.44
EBIT margin %	6.99	7.96	5.79	13.14	14.87	9.98	15.81	-4.14
FCF / sales %	2.78	5.01	13.58	11.41	9.45	10.39	10.20	7.55
Current ratio	1.73	1.88	1.80	1.71	1.60	1.61	1.07	1.78
Quick ratio	1.02	1.09	1.13	1.05	0.96	0.95	0.65	1.04
Debt / assets	69.86	52.35	49.40	50.54	46.70	42.68	33.48	33.46
LT debt / equity	--	344.39	291.36	218.52	121.99	100.46	54.30	70.36
Interest coverage	0.78	1.09	1.20	4.46	4.20	2.44	4.90	-1.60
Revenue CAGR (3Y) %	--	105.97	72.42	7.99	7.54	2.91	-2.80	-4.46
Net income CAGR (3Y) %	--	--	--	--	162.86	40.17	7.51	--
FCF CAGR (3Y) %	--	91.59	--	72.97	32.92	-5.89	-6.35	-11.34

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
ROE %	12.52	11.73	-1.48	-9.20	-9.44	-9.70
ROA %	5.70	5.40	-0.67	-4.44	-4.60	-4.74
ROIC %	8.43	7.94	0.56	-4.06	-4.58	-4.82
5-year avg ROE %	--	--	--	--	--	--
EBIT margin %	15.79	15.08	3.60	-4.14	-4.59	-4.66
FCF / sales %	9.97	8.34	7.96	7.55	6.70	6.93
Current ratio	1.12	0.98	1.49	1.78	1.76	1.78
Quick ratio	0.69	0.62	0.88	1.04	1.01	1.05
Debt / assets	33.32	33.20	33.04	33.46	32.72	31.89
LT debt / equity	53.77	47.54	65.31	70.36	67.62	65.02
Interest coverage	5.37	5.61	1.36	-1.60	-1.77	-1.83
Revenue CAGR (3Y) %	--	--	--	--	--	--
Net income CAGR (3Y) %	--	--	--	--	--	--
FCF CAGR (3Y) %	--	--	--	--	--	--

✦ Quant Revenue Concentration how this is computed

Single-engine

VWR Distribution & Services is the largest reported line at 73.30% of revenue, across 2 reported segments.
The next-largest line, Bioscience & Medtech Products, is a distant second at 26.70% - a sharp slowdown here would have little to offset it.

Revenue breakdown most recent period

Business

VWR Distribution & Services73.30%

Bioscience & Medtech Products26.70%

Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.